These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 19148943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of hearing in very young children receiving carboplatin for retinoblastoma.
    Smits C, Swen SJ, Theo Goverts S, Moll AC, Imhof SM, Schouten-van Meeteren AY.
    Eur J Cancer; 2006 Mar; 42(4):492-500. PubMed ID: 16376542
    [Abstract] [Full Text] [Related]

  • 4. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
    Lumbroso L, Doz F, Levy C, Dendale R, Vedrenne J, Bours D, Zucker JM, Asselain B, Desjardins L.
    J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH, Frank CM, Dunkel IJ.
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [Abstract] [Full Text] [Related]

  • 10. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M, Brandolini C, Ferri GG, Hatzopoulos S, Prete A, Pession A.
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Neuwelt EA, Gilmer-Knight K, Lacy C, Nicholson HS, Kraemer DF, Doolittle ND, Hornig GW, Muldoon LL.
    Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study.
    Bergeron C, Dubourg L, Chastagner P, Mechinaud F, Plouvier E, Desfachelles AS, Dusol F, Pautard B, Edan C, Plantaz D, Froehlich P, Rubie H.
    Pediatr Blood Cancer; 2005 Jul; 45(1):32-6. PubMed ID: 15768383
    [Abstract] [Full Text] [Related]

  • 16. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.
    Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR.
    Bone Marrow Transplant; 1998 Oct; 22(7):669-74. PubMed ID: 9818694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carboplatin ototoxicity in retinoblastoma: onset and monitoring.
    Shearer P.
    Pediatr Blood Cancer; 2009 Sep; 53(3):517. PubMed ID: 19484758
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.